Why Wall Street and Jim Cramer Think Danaher Stock Is 'Ready to Play'
Danaher is finally turning the corner. CNBC's Jim Cramer sees it. Wall Street does it too. Life sciences stocks are…
health care industry
Pfizer reaches agreement with YaoPharma for an anti-obesity pill
Pfizer CEO Albert Bourla speaks during a press conference with European Commission President Ursula von der Leyen after a visit…
FDA May Add Stricter Safety Warning to Covid Shots
A version of this article first appeared in CNBC's Healthy Returns newsletter, bringing the latest healthcare news directly to your…
Food brands chase Fibermaxxing trend with new fiber-rich products
Workers hang on a Pepsi sign on a building outside Allegiant Stadium ahead of LVIII in Las Vegas, Nevada, USA,…
Eli Lilly's weight-loss drug retatrutide clears first late-stage study
The Eli Lilly logo appears at the company's office in San Diego, California, USA, on November 21, 2025. Mike Blake…
A biotech stock for investors who fear investing in the risky industry
Citigroup believes investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the…
Eli Lilly to build $6 billion manufacturing plant in Alabama
Eli Lilly CEO David A. Ricks speaks at a news conference at Generation Park in Houston, Monday, Sept. 23, 2025.…
FDA approves Merck drug for decimated cattle herds to stop screwworm
Cattle detained in the pens of the Unión Ganadera Regional de Chihuahua, at the Jerónimo-Santa Teresa border crossing in Ciudad…
Bill Gates explains why AI will become “hypercompetitive”
Bill Gates speaks to CNBC at Abu Dhabi Finance Week. CNBC Bill Gates has warned that some highly valued AI…
RFK Jr. panel weakens guidance
Health and Human Services Secretary Robert F. Kennedy Jr.'s hand-picked vaccine committee voted Friday to eliminate the long-standing universal recommendation…